Publications and Presentations
INTELLECTUAL PROPERTY
Turgul, V., Moschos, S.A., Kale, I. (2019) Impactor for Aerosol Component Collection. WO2019053423. Priority date 12th September 2017, published 21st March 2019.
https://patents.google.com/patent/EP3681407B1/
Moschos, S.A. & Kale I. (2017) Exhaled breath condensate collection device & a kit of parts thereof. WO2017153755A1. Priority date 8th March 2016 , published 14th September 2017.
https://patents.google.com/patent/US20220218229A1/
SCIENTIFIC PUBLICATIONS
Moschos, S., Jajah, E., Almeida, P., Athanasiou, N., Nikolouzakis, T., Henderson, J., Ali, S., Mantso, T., Kofteridis, D., Zafiropoulos, A., Rokka, C., Queiroz, D., Tsatsakis, A., Kotanidou, A., Lagiou, P., Gauiar, R., Teixeira, M., Magiorkinis, G., Katsaounou, P. SARS-CoV-2 load in exhaled end-tidal breath fine aerosol condensates among acutely symptomatic COVID-19 cases. ERJ 2022 60: 4515.
https://erj.ersjournals.com/content/60/suppl_66/4515
Henderson, J., Mantso, T., Ali, S., Groß, R., Müller, J.A., Wilkinson, A., Shah, K., Usher, L., Auld, B., Nelson, A., Cheung, W., Namdeo, A., Combrinck, M., Hackney, P., Turgul, V., Jahaj, E., Athanasiou, N., Nikolouzakis, Almeida, P.J., T., Rokka, C., Queiroz, D.C., Wright, E., Zafiropoulos, A., Kale, I., Smith, D., Kofteridis, D.P., Tsatsakis, A., Münch, J., Katsaounou, P.A., Kotanidou, A., Lagiou, P., Magiorkinis, G., Aquiar, R.S., Teixeira, M.M, and Moschos, S.A. Airborne Pathogen Detection in Fine Aerosol Exhaled Breath Condensates 2022
https://www.medrxiv.org/content/10.1101/2022.05.25.22275435v2
Henderson, J., Gross, R., Moschos, S.A, Ali, S., Mantso, T., Wright, E., Mueller, W.R., Mueller, J., Muench, J. Capture efficiency of mechanically nebulised synthetic nanoparticles, liposomes, SARS-CoV-2 virus-like particles, and infectious pseudotyped virions is influenced by particle surface charge. ERJ 2021 58. (Suppl. 65): PA2368.
https://erj.ersjournals.com/content/58/suppl_65/PA2368
ORAL PRESENTATIONS
KEYNOTE: ‘Gases, Volatiles, Cytokines, Mutations: Personalised Lung Medicine through Breath Diagnostics’. 4th International Congress on Pharmacogenomics and Personalized Diagnosis and Therapy: Precision Medicine in Disease, Diagnosis and Therapy, 1-3rd December 2023, Athens, Greece, EU.
Video link: https://www.youtube.com/watch?v=8amVkwdS55I&list=PLPzInO4nqiMtT47ct9qTLfuGq5eXvCyTB&index=4
‘An SME Perspective of Collaboration with Corporates.’ European Enterprise Network Annual Conference, 15-17th November 2023, Bilbao, Spain, EU.
‘100% SARS-CoV-2 Genome Detection in Saliva-Free Distal Airway Fraction Exhaled Breath.’ Cambridge Healthtech Institute’s 30th International Point-of-Care Diagnostics for Global Health & Biodefense: Advanced Methods to Enable Critical Decision-Making, 7-8th June 2023, Bethesda, MA, USA.
‘Deep lung fine aerosols as a novel sample for translational biomarker discovery.’ Oxford Global’s NextGen Omics UK, 9th-10th November 2022, London, UK
‘Non-Invasive Deep Lung Sampling’ Northern Accelerator’s Celebration Event, 21st July 2022, Newcastle Upon Tyne, UK.
‘Non-invasive deep lung sampling’ BioNOW 2022, 22nd June 2022, Gateshead, Tyne and Wear, UK.
'COVID-19 Diagnosis Through qRT-PCR In Exhaled Breath Using A Novel Hand-Held Breath Sampler' Oxford Global’s NGS and Single Cell Analysis Congress: Virtual, Nov 2021.
'Non-invasive Deep Lung Sampling' BioCap 2021 Conference, Virtual, Sep 2021.
'Fractionated exhaled breath aqueous particle sampling for diagnostic bioanalytics of COVID19’ European Aerosol Conference 2021, Aug-Sep 2021.
‘Understanding SARS-CoV2 airborne transmission: the role of exhaled breath’ Centre for Research on Biomolecular Interactions, Department of Chemistry, York University Toronto, Canada, June 2021.
‘Take My Breath Away: Exhaled Breath Condensate-based Airborne Pathogen Detection’. Microbiology Society Annual Conference Online 2021, 26-30th April 2021, UK.
‘Exhaled breath microbiomics and amplicon-based biomonitoring’ Oxford Global’s NGS and Single Cell Analysis Congress: Virtual, Nov 2020.
‘KEYNOTE: Resolving cytosolic molecular therapy for lung diseases: targeting, delivery, bioanalysis, diagnostics’. United Scientific Groups’ 5th International Conference on Drug Discovery Development and Lead Optimization, Oct 2020, Bufallo, NY, USA.
‘Infectious and genetic viral load in exhaled breath aerosols’ SARS-CoV-2 and COVID-19 Online Workshop, Microbiology Society (UK), July 2020.
CONFERENCE POSTERS
Moschos, S.A., Jahaj, E., Athanasiou, N., Nikolouzakis T., Henderson, J., Ali S., Mantso, T., Kofteridis, D.P., Zafiropoulos, A., Rokka, C., Tsatsakis, A., Katsaounou, P.A., Kotanidou, A., Lagiou, P., and Magiorkinis, G. SARS-CoV-2 load in exhaled end-tidal breath fine aerosol condensates among acutely symptomatic COVID-19 cases. European Respiratory Society International Congress, Barcelona, Spain, Sep 2022, in person. Abstract no. 36670.
Henderson, J., Groß, R., Moschos, S.A., Ali, S., Mantso, T., Wright, E., Müller, E., and Münch, J. Capture efficiency of mechanically nebulised synthetic nanoparticles, liposomes, SARS-CoV-2 virus-like particles, and infectious pseudotyped virions is influenced by particle surface charge. European Respiratory Society International Congress Aug-Sep 2021, online. Abstract no. 3964.
PRE-INCORPORATION PRESENTATIONS
‘xHALEscreen™ : exhaled breath condensate biomarkers & diagnostics’. Cambridge Healthcare Institute’s 5th Annual Sensors summit, San Diego, CA., USA Dec 2019.
‘xHALEscreen™ : exhaled breath condensate to respiratory research and clinical diagnostics; answering the unmet need of diagnosing asthma in pre-school children. ICURe NxNW Cohort C Investor Day, Nexus, University of Leeds, Nov. 2019.
‘Standardisation and reproducibility of exhaled breath condensate collection using xHALEscreen™’ Royal Brompton Hospital, National Heart & Lung Institute, Imperial College, London, Nov. 2019.
POSTER: Canyelles-Pericas, P., & Moschos, S.A. xHALEscreen™: An Exhaled Breath & Environment Aerosol Condensate Capture Platform for Molecular Bioanalytics in Biodefence. Cambridge Healthtech institute’s 5th Annual Biodefense World Summit 2019, Bethesda, MD, USA.
‘PulmoScreen: Solving Exhaled Breath Molecular Diagnostics’. Graviton Events’ Molecular Diagnostics World Summit 2018, London, UK, Nov 2018 (invited oral presentation).
POSTER: Clements, C., Wilkinson, A., Shah, K, & Moschos, S.A. PulmoScreen: A novel exhaled breath condensate device. Graviton Events Molecular Diagnostics World Summit 2018, London, UK.
POSTER: Wilkinson, A., Usher, L., Mackenzie, R., Kale, I. & Moschos, S.A. Pulmoscreen: towards the first autonomous respiratory microbiome biosensor. Sensors in Medicine 2014, London, UK.